Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

NBTY Balance Sheet Has Firm Positioned For Acquisitions In FY ’03

This article was originally published in The Tan Sheet

Executive Summary

NBTY plans to pursue acquisitions more actively after increasing working capital and reducing bank debt over the past fiscal year, President & CFO Harvey Kamil said during a Nov. 6 analysts call

You may also be interested in...



Ephedra Weight-Loss Claims “Inappropriate,” FDA’s Crawford Says

Weight-loss and energy enhancement claims are "inappropriate" for ephedra-containing products, FDA Acting Commissioner Lester Crawford, PhD, said during an Oct. 8 Senate subcommittee hearing

NBTY acquisition

Multi-level marketer purchases Synergy Plus dietary supplement line of roughly 300 SKUs on Aug. 7; details of the acquisition were not disclosed. Synergy Plus franchise, which has been available exclusively in health food stores for over 30 years, includes numerous vitamin, mineral and herbal supplements. NBTY notes acquisition is in line with firm's plans to expand its wholesale business with niche products; Knox NutraJoint joint, nail health supplements extended the firm's portfolio in December (1"The Tan Sheet" Dec. 24, 2001, In Brief)...

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS094769

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel